PharmaBoardroom

Interview with Stephen Merrick, President, Bristol-Myers Squibb…

Two days ago, the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming…

Interview with Xander Bos, General Manager, Boehringer Ingelheim…

While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general…

Interview with Imanda Wapenaar, Executive Director, WestHolland…

WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week…

Interview with Maria Del Pilar Muñoz, Director of Sustainability…

Your position unites two somewhat incongruous titles – Director of Sustainability, and New Business. How did this come to be, and what if any…

Interview with Sebastiano Castorina, CEO, Takeda Italy

Takeda has more than 25 years of history in Italy and reached the 20th position in the Italian market- a striking performance in a context when it is…

Interview with Ewe Kheng Huat, Managing Director, Merck Sharp…

Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…

Interview with Jeh Ping Chang, General Manager, OEP Philippines

Mr. Chang, can you please give an overview of the establishment of OEP Philippines and the company’s current activities here? OEP Philippines…

Interview with Martin Nelzow, CEO, Boehringer Ingelheim Brazil

You came to Boehringer Ingelheim in 2009 – what are some of the most exciting milestones and achievements you have presided over during this…

Interview with Sergio Daniotti, Country Manager, Boehringer…

The main distinctive point of Boehringer Ingelheim Italy within the group is its business structure, which relies on three different units: Boehringer…